Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed to Present Preclinical Data Demonstrating Cytotoxic Activity of its Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA)

May 12, 2022

Affimed Provides Update on ASCO AFM13-104 Oral Presentation

May 6, 2022

Affimed Announces Clinical Update and Trial in Progress Posters at the Annual Meeting of the American Society of Clinical Oncology (ASCO)

April 27, 2022

Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

April 18, 2022

Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares

April 13, 2022

Affimed Announces Proposed Public Offering of Common Shares

April 12, 2022

Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting

April 10, 2022

Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors

April 8, 2022

Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress

March 31, 2022

Affimed to Report Full Year 2021 Financial Results & Corporate Update on March 31, 2022

March 24, 2022

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28

Events

All
Scientific
Investors

28Mar

Innate Killer Summit

March 28 - 30, 2023 (San Diego, USA)

14Apr

AACR Annual Meeting 2023

April 14 - 19, 2023 (Orlando, Florida)

23Apr

EBMT 49th Annual Meeting

April 23 - 26, 2023 (Paris, France)

WebcastsMore events

Affimed GmbH
Technologiepark
Im Neuenheimer Feld 582
69120 Heidelberg, Germany

Phone: +49 (0)6221-6743-60
Fax: +49 (0)6221 6743-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2023 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact